VEDO300MG — Vedolizumab 300 Mg/5 Ml Sdv
$6,998
All-payer median here
$4,666
Cash / self-pay here
11
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.